1. Absorption Kinetics after Inhalation of Fluticasone Propionate via the Diskhaler®, Diskus® and Metered-Dose Inhaler in Healthy Volunteers

   • Charles Brindley
   • Christine Falcoz
   • Alan Bye

   Original Research Article 18 October 2012 Pages: 1 - 8

   

2. Bioavailability of Orally Administered Micronised Fluticasone Propionate

   • Christine Falcoz
   • Ruth Oliver
   • Peter T. Daley-Yates

   Original Research Article 18 October 2012 Pages: 9 - 15

   

3. Systemic Exposure to Fluticasone Propionate Administered via Metered-Dose Inhaler Containing Chlorofluorocarbon or Hydrofluoroalkane Propellant

   • Alison E. Mackie
   • Jo E. McDowall
   • Peter T. Daley-Yates

   Original Research Article 18 October 2012 Pages: 17 - 22

   

4. Pharmacokinetics of Fluticasone Propionate Inhaled via the Diskhaler® and Diskus® Powder Devices in Healthy Volunteers

   • Alison E. Mackie
   • Jo E. McDowall
   • Peter T. Daley-Yates

   Original Research Article 18 October 2012 Pages: 23 - 30

   

5. Pharmacokinetics of Fluticasone Propionate Inhaled via the Diskhaler® and Diskus® Powder Devices in Patients with Mild-to-Moderate Asthma

   • Christine Falcoz
   • John Horton
   • Peter T. Daley-Yates

   Original Research Article 18 October 2012 Pages: 31 - 37

   

6. Comparison of the Systemic Availability of Fluticasone Propionate in Healthy Volunteers and Patients with Asthma

   • Peter T. Daley-Yates
   • Julien Tournant
   • Robert L. Kunka

   Original Research Article 18 October 2012 Pages: 39 - 45

   

7. The Relationship between Systemic Exposure to Fluticasone Propionate and Cortisol Reduction in Healthy Male Volunteers

   • Alison E. Mackie
   • Alan Bye

   Original Research Article 18 October 2012 Pages: 47 - 64